{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:11:44Z","timestamp":1794413504224,"version":"4.9.1"},"reference-count":40,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,1,15]]},"DOI":"10.2169\/internalmedicine.9743-22","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T22:10:21Z","timestamp":1655158221000},"page":"243-249","source":"Crossref","is-referenced-by-count":3,"title":["Concurrent &lt;i&gt;de novo&lt;\/i&gt; Thymoma-associated Paraneoplastic Type 1 Autoimmune Hepatitis and Pure Red Cell Aplasia after Thymectomy: A Case Report and Literature Review"],"prefix":"10.2169","volume":"62","author":[{"given":"Rie","family":"Sakata","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"},{"name":"Postgraduate Medical Education Center, Keio University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-sung","family":"Chu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Kawaida","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsura","family":"Emoto","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Nishida","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Asakura","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Taniki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 72: 671-722, 2020.","DOI":"10.1002\/hep.31065"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Czaja AJ. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. World J Gastroenterol 25: 6579-6606, 2019.","DOI":"10.3748\/wjg.v25.i45.6579"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol 19: 158-176, 2022.","DOI":"10.1038\/s41423-021-00768-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: autoimmune hepatitis. J Hepatol 63: 971-1004, 2015.","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bluestone JA, Anderson M. Tolerance in the age of immunotherapy. N Engl J Med 383: 1156-1166, 2020.","DOI":"10.1056\/NEJMra1911109"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shelly S, Agmon-Levin N, Altman A, et al. Thymoma and autoimmunity. Cell Mol Immunol 8: 199-202, 2011.","DOI":"10.1038\/cmi.2010.74"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bernard C, Frih H, Pasquet F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev 15: 82-92, 2016.","DOI":"10.1016\/j.autrev.2015.09.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Blum TG, Misch D, Kollmeier J, et al. Autoimmune disorders and paraneoplastic syndromes in thymoma. J Thorac Dis 12: 7571-7590, 2020.","DOI":"10.21037\/jtd-2019-thym-10"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Emeryk B, Strugalska MH. Evaluation of results of thymectomy in myasthenia gravis. J Neurol 211: 155-168, 1976.","DOI":"10.1007\/BF00313359"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Okumura M, Fujii Y, Shiono H, et al. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg 56: 143-150, 2008.","DOI":"10.1007\/s11748-007-0185-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Thompson CA, Steensma DP. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol 135: 405-407, 2006.","DOI":"10.1111\/j.1365-2141.2006.06295.x"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Hirokawa M, Sawada K, Fujishima N, et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica 93: 27-33, 2008.","DOI":"10.3324\/haematol.11655"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takikawa H, Onji M. A proposal of the diagnostic scale of drug-induced liver injury. Hepatol Res 32: 250-251, 2005.","DOI":"10.1016\/j.hepres.2005.05.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46: 1323-1330, 1993.","DOI":"10.1016\/0895-4356(93)90101-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nguyen Canh H, Harada K, Ouchi H, et al.; Intractable Liver and Biliary Diseases Study Group of Japan. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol 70: 961-969, 2017.","DOI":"10.1136\/jclinpath-2016-204271"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ko KF, Ho T, Chan KW. Autoimmune chronic active hepatitis and polymyositis in a patient with myasthenia gravis and thymoma. J Neurol Neurosurg Psychiatry 59: 558-559, 1995.","DOI":"10.1136\/jnnp.59.5.558"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Han YS, Kim BH, Kim TH, et al. Autoimmune hepatitis in a patient with myasthenia gravis and thymoma - a report on the first case in Korea. Korean J Intern Med 15: 151-155, 2000.","DOI":"10.3904\/kjim.2000.15.2.151"},{"key":"18","unstructured":"18. Asakawa H, Kashihara T, Fukuda H, et al. A patient with thymoma and four different organ-specific autoimmune diseases. Neth J Med 60: 292-295, 2002."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Aigner E, Strassburg CP, Strasser M, et al. Transient autoimmune hepatitis induced by a thymoma. Am J Gastroenterol 104: 1332-1334, 2009.","DOI":"10.1038\/ajg.2009.99"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yapali S, Oruc N, Ilgun S, et al. Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder. Hepatol Res 42: 835-839, 2012.","DOI":"10.1111\/j.1872-034X.2012.00985.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rajan A, Kotlyar D, Giaccone G. Acute autoimmune hepatitis, myositis, and myasthenic crisis in a patient with thymoma. J Thorac Oncol 8: e87-e88, 2013.","DOI":"10.1097\/JTO.0b013e318298832b"},{"key":"22","unstructured":"22. Mejri N, Chabchoub I, Gargouri I, et al. Effect of chemotherapy on autoimmune hepatitis in thymoma: a case report and literature review. Cancer Biol Med 10: 169-173, 2013."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mendogni P, Rosso L, Tosi D, et al. Autoimmune hepatitis: an uncommon presentation of thymoma. Tumori 102: 2016.","DOI":"10.5301\/tj.5000505"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Feinsilber D, Mears KA, Pettiford BL. Polyparaneoplastic manifestations of malignant thymoma: a unique case of myasthenia, autoimmune hepatitis, pure red cell aplasia, and keratoconjunctivitis sicca. Cureus 9: e1374, 2017.","DOI":"10.7759\/cureus.1374"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nishimura T, Tsunezuka H, Miyata N, et al. Autoimmune hepatitis during preoperative chemotherapy in a patient with thymoma. Interact Cardiovasc Thorac Surg 29: 635-637, 2019.","DOI":"10.1093\/icvts\/ivz138"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Stilwell KT, Musick SR, Cebe KM, et al. Thymoma-induced autoimmune hepatitis: a rare paraneoplastic syndrome. Cureus 11: e5637, 2019.","DOI":"10.7759\/cureus.5637"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rossi SW, Kim MY, Leibbrandt A, et al. RANK signals from CD4<sup>+<\/sup>3<sup>-<\/sup> inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med 204: 1267-1272, 2007.","DOI":"10.1084\/jem.20062497"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Marx A, Yamada Y, Simon-Keller K, et al. Thymus and autoimmunity. Semin Immunopathol 43: 45-64, 2021.","DOI":"10.1007\/s00281-021-00842-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mollaeian A, Haas C. A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus. Clin Rheumatol 39: 2227-2234, 2020.","DOI":"10.1007\/s10067-020-05061-z"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nitta H, Mihara K, Sakai A, et al. Expansion of CD8<sup>+<\/sup>\/perforin<sup>+<\/sup> effector memory T cells in the bone marrow of patients with thymoma-associated pure red cell aplasia. Br J Haematol 150: 712-715, 2010.","DOI":"10.1111\/j.1365-2141.2010.08273.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Chapin CA, Burn T, Meijome T, et al. Indeterminate pediatric acute liver failure is uniquely characterized by a CD103<sup>+<\/sup>CD8<sup>+<\/sup> T-cell infiltrate. Hepatology 68: 1087-1100, 2018.","DOI":"10.1002\/hep.29901"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yu XT, Yu L, Du X, et al. Clinical and genetic characteristics of thymoma patients with autoimmune hepatitis and myocarditis. Front Oncol 11: 746304, 2021.","DOI":"10.3389\/fonc.2021.746304"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Rauff B, Idrees M, Shah SA, et al. Hepatitis associated aplastic anemia: a review. Virol J 8: 87, 2011.","DOI":"10.1186\/1743-422X-8-87"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Gerli R, Paganelli R, Cossarizza A, et al. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 103: 865-872, 1999.","DOI":"10.1016\/S0091-6749(99)70431-8"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Kido M, Watanabe N, Okazaki T, et al. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology 135: 1333-1343, 2008.","DOI":"10.1053\/j.gastro.2008.06.042"},{"key":"36","first-page":"621","volume":"38","author":"BH Toh","year":"1979","unstructured":"36. Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 38: 621-628, 1979.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Clemente MG, Obermayer-Straub P, Meloni A, et al. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 82: 1353-1361, 1997.","DOI":"10.1210\/jc.82.5.1353"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Means RT Jr. Pure red cell aplasia. Hematology Am Soc Hematol Educ Program 2016: 51-56, 2016.","DOI":"10.1182\/asheducation-2016.1.51"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142: 505-514, 2008.","DOI":"10.1111\/j.1365-2141.2008.07216.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Noguchi F, Chu PS, Taniki N, et al. Long-term observation of cyclosporine as second-line therapy in adults for severe acute autoimmune hepatitis. Hepatology 73: 2594-2597, 2021.","DOI":"10.1002\/hep.31597"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/2\/62_9743-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:16Z","timestamp":1715315476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/2\/62_9743-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9743-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,15]]},"article-number":"9743-22"}}